Published in Transfus Clin Biol on June 01, 2001
Pre-birth selection of umbilical cord blood donors. Blood Transfus (2010) 1.02
Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation. Blood (2010) 0.97
Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells. Blood (2010) 0.95
Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis. Stem Cell Res (2012) 0.91
Concern Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment. Clin Med Oncol (2008) 0.86
Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse. Exp Biol Med (Maywood) (2009) 0.82
Expansion of cord blood CD34 cells in presence of zVADfmk and zLLYfmk improved their in vitro functionality and in vivo engraftment in NOD/SCID mouse. PLoS One (2010) 0.81
Migration of human umbilical cord blood cells into rat liver. Int J Stem Cells (2010) 0.77
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis (1991) 4.74
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med (1997) 4.71
Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med (2001) 3.98
Half the families of intensive care unit patients experience inadequate communication with physicians. Crit Care Med (2000) 3.78
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Iatrogenic complications in adult intensive care units: a prospective two-center study. Crit Care Med (1993) 2.84
Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med (2007) 2.65
Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol (1999) 2.63
A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N Engl J Med (1992) 2.51
Preparation of cellular plant organelles from spinach leaves. Arch Biochem Biophys (1970) 2.47
French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy. Crit Care Med (2001) 2.39
Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infect Control Hosp Epidemiol (1997) 2.16
Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis (1996) 2.14
Malate dehydrogenases of leaf tissue from Spinacia oleracea: properties of three isoenzymes. Arch Biochem Biophys (1971) 2.00
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant (2009) 2.00
Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol (2003) 1.86
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut (2000) 1.84
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia (2009) 1.80
Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant (2005) 1.79
Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood (1996) 1.78
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia (2006) 1.77
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood (2001) 1.74
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat (2002) 1.71
Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Crit Care Med (1993) 1.68
Comparative immunological and enzymatic study of the tryptophan synthetase beta 2 subunit in the Enterobacteriaceae. J Bacteriol (1972) 1.68
NADP-specific malate dehydrogenase of green spinach leaf tissue. Arch Biochem Biophys (1971) 1.64
A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients. Leukemia (2004) 1.63
Plasma exchange morbidity in Guillain-Barré syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit Care Med (1993) 1.62
Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus. Crit Care Med (1999) 1.62
Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol (1996) 1.58
Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med (1997) 1.57
Splenectomy is safe and effective in human immunodeficiency virus-related immune thrombocytopenia. Blood (1993) 1.55
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant (2006) 1.53
A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol (2002) 1.52
Meeting the needs of intensive care unit patient families: a multicenter study. Am J Respir Crit Care Med (2001) 1.52
Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis (1996) 1.51
Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol (1997) 1.46
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Leukemia (2005) 1.44
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia (1998) 1.42
Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant (2006) 1.42
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood (1999) 1.42
B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. Blood (1991) 1.40
Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level. Br J Haematol (1997) 1.40
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. J Clin Oncol (2000) 1.39
[Comparison of pre-induction ultrasonographic cervical length and Bishop score in predicting risk of cesarean section after labor induction with prostaglandins]. Gynecol Obstet Fertil (2004) 1.39
The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant (2009) 1.37
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. Br J Haematol (2000) 1.37
Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis (1999) 1.33
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia (2000) 1.31
Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study. Stat Med (1991) 1.29
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant (2007) 1.28
Compliance with triage to intensive care recommendations. Crit Care Med (2001) 1.28
A comparative study of the regulation of nicotinamide-adenine dinucleotide biosynthesis. Biochim Biophys Acta (1968) 1.27
The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr (1997) 1.26
Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor. Clin Exp Immunol (2013) 1.26
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia (2011) 1.24
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2007) 1.21
Acute vertebral collapse due to osteoporosis or malignancy: appearance on unenhanced and gadolinium-enhanced MR images. Radiology (1996) 1.20
Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis (1996) 1.20
Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2002) 1.20
Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am J Transplant (2008) 1.20
High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant (2005) 1.19
History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy (2005) 1.19
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis (2000) 1.19
Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT. Bone Marrow Transplant (2012) 1.16
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol (2002) 1.15
Breathing disorders during sleep in myasthenia gravis. Ann Neurol (1992) 1.15
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products. Bone Marrow Transplant (2007) 1.13
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol (2004) 1.13
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. Leukemia (2003) 1.13
Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children -- a Eurocord analysis. Br J Haematol (2001) 1.12
Immunochemical comparison of phosphoribosylanthranilate isomerase-indoleglycerol phosphate synthetase among the Enterobacteriaceae. J Bacteriol (1977) 1.10
The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies. Stat Med (2001) 1.08
Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group. J Neurol Neurosurg Psychiatry (1995) 1.08
Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis. J Clin Epidemiol (2001) 1.06
Impact of comorbidity indexes on non-relapse mortality. Leukemia (2008) 1.06
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group. Leukemia (2006) 1.06
Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2007) 1.05
Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev (2002) 1.05
Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J (2008) 1.04
Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer (1996) 1.03
Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol (2001) 1.03
Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis (1996) 1.02
Accuracy of a composite score using daily SAPS II and LOD scores for predicting hospital mortality in ICU patients hospitalized for more than 72 h. Intensive Care Med (2001) 1.01
Chloroplast-malic dehydrogenase: a new malic dehydrogenase isozyme from spinach. Biochem Biophys Res Commun (1968) 1.00
Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax (1994) 1.00
Purification and partial characterization of the B subunit of Serratia marcescens tryptophan synthetase. J Bacteriol (1978) 0.99
Casein production during differentiation of mammary epithelial cells in collagen gel culture. Exp Cell Res (1985) 0.99
Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases. Transpl Infect Dis (2011) 0.99
Visit-driven endpoints in randomized HIV/AIDS clinical trials: impact of missing data on treatment difference measured on summary statistics. Stat Med (1999) 0.99